{{knowledge objective
|Identifiant=OIC-023-09-B
|Item_parent=Normal pregnancy
|Item_parent_short=Normal pregnancy
|Rank=B
|Title=Conduct in the event of a positive T21 test
|Description=Knowing how to explain the results and suggest additional tests depending on the risk
|Rubric=Management
|Contributors=Philippe Deruelle,Laurence Compagnon
|Order=9}}


== Risk > 1/ 50 ==
= fetal karyotype by trophoblast biopsy or amniocentesis

== Risk between 1/51 and 1/1000 ==
= non-invasive prenatal screening (lcT21 DNA test - analysis of free foetal DNA circulating in maternal blood), if amniocentesis is requested, possible but not reimbursed SS

== Risk < 1000 ==
= no further tests recommended and screening stopped